Abstract
In vitro radical-cation scavenging capacity and anti-AChE activities of 19 piperidine derivatives, including dihydrospiro[ piperidine-4,2(1H)quinolines] 7-19 and their precursor 4-allyl-4-arylaminopiperidines 1-6 were reported. Their data of bioassays and calculated logP and TPSA parameters showed promising drug-like properties. The best radical scavenging compound (TEAC 1.73 ± 0.01), 6-methyl-3,4- dihydrospiro[piperidine-4,2(1H)quinoline] 8 showed IC50 value of 62.5 μM (20.0 μg/mL) using AChE assay.
Keywords: Antioxidant capacity, AChE inhibitory activity, Intramolecular Friedel-Crafts cyclization, Dihydrospiro[piperidine-4,2'(1'H)quinoline] derivatives, Multifunctional drug discovery, 4-allyl-4-arylaminopiperidines, AChE assay, Alzheimer's disease, AD, tacrine, rivas-tigmine, donepezil, galantamine, acetylcholine, hyperphosphory-lation, tacrine-ferullic hybrids, tacrine-melatonin, TMTHQ, Physostigmine, Trolox, Toluene, Allylmagnesium bromide, H-NMR, C-NMR, TPSA, BHT, 2,6-di-tert-butyl-4-methylphenol, BHA, 2-tert-butyl-4-hydroxyanisol, Trolox® Equivalent Antioxidant Capacity, TEAC, Ellman's reagent, DTNB, 5,5'-dithio-bis-2-nitrobenzoic acid, N-benzyl-6-methyl-3',4'-dihydrospiro[piperi-dine-4,2'(1'H)quinoline], N-benzyldihydrospiro[piperi-dine-4,2'(1'H)quinoline]
Letters in Drug Design & Discovery
Title: 3,4-Dihydrospiro[piperidine-4,2-(1H)quinoline] Derivatives as New Antioxidant Agents with Acetylcholinesterase Inhibitory Property
Volume: 7 Issue: 10
Author(s): Vladimir V. Kouznetsov, Leonor Y. Vargas Mendez and Amner Munoz Acevedo
Affiliation:
Keywords: Antioxidant capacity, AChE inhibitory activity, Intramolecular Friedel-Crafts cyclization, Dihydrospiro[piperidine-4,2'(1'H)quinoline] derivatives, Multifunctional drug discovery, 4-allyl-4-arylaminopiperidines, AChE assay, Alzheimer's disease, AD, tacrine, rivas-tigmine, donepezil, galantamine, acetylcholine, hyperphosphory-lation, tacrine-ferullic hybrids, tacrine-melatonin, TMTHQ, Physostigmine, Trolox, Toluene, Allylmagnesium bromide, H-NMR, C-NMR, TPSA, BHT, 2,6-di-tert-butyl-4-methylphenol, BHA, 2-tert-butyl-4-hydroxyanisol, Trolox® Equivalent Antioxidant Capacity, TEAC, Ellman's reagent, DTNB, 5,5'-dithio-bis-2-nitrobenzoic acid, N-benzyl-6-methyl-3',4'-dihydrospiro[piperi-dine-4,2'(1'H)quinoline], N-benzyldihydrospiro[piperi-dine-4,2'(1'H)quinoline]
Abstract: In vitro radical-cation scavenging capacity and anti-AChE activities of 19 piperidine derivatives, including dihydrospiro[ piperidine-4,2(1H)quinolines] 7-19 and their precursor 4-allyl-4-arylaminopiperidines 1-6 were reported. Their data of bioassays and calculated logP and TPSA parameters showed promising drug-like properties. The best radical scavenging compound (TEAC 1.73 ± 0.01), 6-methyl-3,4- dihydrospiro[piperidine-4,2(1H)quinoline] 8 showed IC50 value of 62.5 μM (20.0 μg/mL) using AChE assay.
Export Options
About this article
Cite this article as:
V. Kouznetsov Vladimir, Y. Vargas Mendez Leonor and Munoz Acevedo Amner, 3,4-Dihydrospiro[piperidine-4,2-(1H)quinoline] Derivatives as New Antioxidant Agents with Acetylcholinesterase Inhibitory Property, Letters in Drug Design & Discovery 2010; 7 (10) . https://dx.doi.org/10.2174/1570180811007010710
DOI https://dx.doi.org/10.2174/1570180811007010710 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Impact and Therapeutic Potential of PPARs in Alzheimers Disease
Current Neuropharmacology Sepsis in the Central Nervous System and Antioxidant Strategies with Nacetylcysteine, Vitamins and Statins
Current Neurovascular Research Brain Ageing, Cognition and Diet: A Review of the Emerging Roles of Food-Based Nootropics in Mitigating Age-related Memory Decline
Current Aging Science Point of NO Return for Nitrergic Nerves in Diabetes: A New Insight into Diabetic Complications
Current Pharmaceutical Design Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease
Current Pharmaceutical Design Uridine Function in the Central Nervous System
Current Topics in Medicinal Chemistry Stroke Risk Stratification Schemes in Atrial Fibrillation in the Era of Non- Vitamin K Anticoagulants: Misleading and Obsolete, At Least for the “Low-Risk” Patients?
Current Drug Targets Amyloid-β Aggregation Inhibitory and Neuroprotective Effects of Xanthohumol and its Derivatives for Alzheimer’s Diseases
Current Alzheimer Research CYP-Mediated Clozapine Interactions: How Predictable Are They?
Current Drug Metabolism Future Targeted Disease Modifying Drugs for Alzheimer's Disease
Recent Patents on CNS Drug Discovery (Discontinued) MTDL Design Strategy in the Context of Alzheimers Disease: From Lipocrine to Memoquin and Beyond
Current Pharmaceutical Design Parkinson's Disease, Diabetes and Cognitive Impairment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Homocysteine in Neurology: From Endothelium to Neurodegeneration
Current Nutrition & Food Science Prevalence and associated factors of sarcopenia in elderly subjects with amnestic mild cognitive impairment or Alzheimer disease.
Current Alzheimer Research The Role of Venous Abnormalities in Neurological Disease
Reviews on Recent Clinical Trials Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update
Current Neuropharmacology Approaching Neurological Diseases to Reduce Mobility Limitations in Older Persons
Current Pharmaceutical Design Therapeutic Effects of Rivastigmine and Alfa-Lipoic Acid Combination in the Charles Bonnet Syndrome: Electroencephalography Correlates
Current Clinical Pharmacology Evidence for Predominance of CCR5-Using HIV-1 Strains During Highly Active Antiretroviral Therapy
Current HIV Research Antioxidant Properties of Melatonin and its Potential Action in Diseases
Current Topics in Medicinal Chemistry